A doxycycline-inducible, tissue-specific aromatase-expressing transgenic mouse

Transgenic Research

Volumn 21, Issue 2, 2012, Pages 415-428

  Chow, Jenny D Y ^a,b   Price, John T ^b   Bills, Margaret M ^b   Simpson, Evan R ^a,b   Boon, Wah Chin ^a,b,c  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Aromatase; Conditional transgenic; Doxycycline; Luciferase; MMTV; Tet ON

Indexed keywords

AROMATASE; COMPLEMENTARY DNA; DOXYCYCLINE; FIREFLY LUCIFERASE;

ANIMAL; ARTICLE; CYTOLOGY; ENZYME ACTIVATION; ENZYME ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HUMAN; LUMINESCENCE; MALE; MAMMARY GLAND; METABOLISM; METHODOLOGY; MICROINJECTION; MOLECULAR CLONING; MOUSE; PLASMID; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND; SEMINAL VESICLE; TRANSGENE; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; AROMATASE; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA, COMPLEMENTARY; DOXYCYCLINE; ENZYME ACTIVATION; ENZYME ASSAYS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC VECTORS; HUMANS; LUCIFERASES, FIREFLY; LUMINESCENT MEASUREMENTS; MALE; MAMMARY GLANDS, HUMAN; MICE; MICE, TRANSGENIC; MICROINJECTIONS; PLASMIDS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALIVARY GLANDS; SEMINAL VESICLES; TRANSGENES;

MOUSE MAMMARY TUMOR VIRUS; MUS; MUS MUSCULUS;

EID: 84859102976     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-011-9525-7     Document Type: Article

References (41)

1. Ackerman GE, Smith ME et al (1981) Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab 53: 412-417.
2. Albanese C, Reutens AT et al (2000) Sustained mammary gland-directed, ponasterone A-inducible expression in transgenic mice. Faseb J 14(7): 877-884.
3. Böcker R, Estler CJ et al (1981) Comparison of distribution of doxycycline in mice after oral and intravenous application measured by a high-performance liquid chromatographic method. Arzneimittelforschung 31(12): 2116-2117.
4. Böcker R, Warnke L et al (1984) Blood and organ concentrations of tetracycline and doxycycline in female mice. Comparison to males. Arzneimittelforschung 34(4): 446-448.
5. Boon WC, Diepstraten J et al (2005) Hippocampal NMDA receptor subunit expression and watermaze learning in estrogen deficient female mice. Mol Brain Res 140(1-2): 127-132.
6. Bulun SE, Sebastian S et al (2003) The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol 86(3-5): 219-224.
7. Carani C, Qin K et al (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337(2): 91-95.
8. Cawthorne C, Swindell R et al (2007) Comparison of doxycycline delivery methods for Tet-inducible gene expression in a subcutaneous xenograft model. J Biomol Tech 18(2): 120-123.
9. Chen D, Reierstad S et al (2009) Regulation of breast cancer-associated aromatase promoters. Cancer Lett 273(1): 15-27.
10. Chow JDY, Simpson ER et al (2009) Alternative 5′-untranslated first exons of the mouse Cyp19A1 (aromatase) gene. J Steroid Biochem Mol Biol 115(3-5): 115-125.
11. Connelly S (1999) Adenoviral vectors for liver-directed gene therapy. Curr Opin Mol Ther 1(5): 565-572.
12. Demura M, Reierstad S et al (2008) Novel promoter I. 8 and promoter usage in the CYP19 (Aromatase) gene. Reprod Sci 15(10): 1044-1053.
13. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89(12): 5547-5551.
14. Gunther EJ, Belka GK et al (2002) A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J 16(3): 283-292.
15. Harada N, Honda S (2005) Analysis of spatiotemporal regulation of aromatase in the brain using transgenic mice. J Steroid Biochem Mol Biol 95(1-5): 49-55.
16. Harada N, Utsumi T et al (1993) Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc Natl Acad Sci USA 90(23): 11312-11316.
17. Harada N, Wakatsuki T et al (2009) Functional analysis of neurosteroidal oestrogen using gene-disrupted and transgenic mice. J Neuroendocrinol 21(4): 365-369.
18. Hinshelwood MM, Mendelson CR (2001) Tissue-specific expression of the human CYP19 (aromatase) gene in ovary and adipose tissue of transgenic mice. J Steroid Biochem Mol Biol 79(1-5): 193-201.
19. Hinshelwood MM, Smith ME et al (2000) A 278 bp region just upstream of the human CYP19 (aromatase) gene mediates ovary-specific expression in transgenic mice. Endocrinology 141(6): 2050-2053.
20. Hruska KS, Tilli MT et al (2002) Conditional over-expression of estrogen receptor alpha in a transgenic mouse model. Transgenic Res 11(4): 361-372.
21. Kamat A, Graves KH et al (1999) A 500-bp region, approximately 40 kb upstream of the human CYP19 (aromatase) gene, mediates placenta-specific expression in transgenic mice. Proc Natl Acad Sci USA 96(8): 4575-4580.
22. Konopka W, Duniec K et al (2009) Tet system in the brain: transgenic rats and lentiviral vectors approach. Genesis 47(4): 274-280.
23. Labbe GG, Fromenty BB et al (1991) Effects of various tetracycline derivatives on in vitro and in vivo beta-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice. Biochem Pharmacol 41(4): 638-641.
24. Lephart ED, Simpson ER (1991) Assay of aromatase activity. Methods Enzymol 206: 477-483.
25. Li X, Nokkala E et al (2001) Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology 142(6): 2435-2442.
26. Maffei L, Murata Y et al (2004) Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 89(1): 61-70.
27. Maffei L, Rochira V et al (2007) A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome. Clin Endocrinol (Oxf) 67(2): 218-224.
28. Mahendroo MS, Mendelson CR et al (1993) Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J Biol Chem 268(26): 19463-19470.
29. McNatty KP, Baird DT et al (1976) Concentration of oestrogens and androgens in human ovarian venous plasma and follicular fluid throughout the menstrual cycle. J Endocrinol 71(1): 77-85.
30. Morishima A, Grumbach MM et al (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80(12): 3689-3698.
31. Robertson KM, O'Donnell L et al (1999) Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. PNAS 96(14): 7986-7991.
32. Ross SR, Hsu CL et al (1990) Negative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic mice. Mol Cell Biol 10(11): 5822-5829.
33. Sasano H, Nagura H et al (1994) Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 25(5): 530-535.
34. Simpson ER (2003) Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86(3-5): 225-230.
35. Simpson ER, Evans CT et al (1987) Sequencing of cDNA inserts encoding aromatase cytochrome P-450 (P-450AROM). Mol Cell Endocrinol 52(3): 267-272.
36. Sjögren K, Lagerquist M et al (2009) Elevated aromatase expression in osteoblasts leads to increased bone mass without systemic adverse effects. J Bone Miner Res 24(7): 1263-1270.
37. Tekmal RR, Ramachandra N et al (1996) Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities. Cancer Res 56(14): 3180-3185.
38. Yamamoto N, Christenson LK et al (2002) Growth differentiation factor-9 inhibits 3′5′-adenosine monophosphate-stimulated steroidogenesis in human granulosa and theca cells. J Clin Endocrinol Metab 87(6): 2849-2856.
39. Yarranton GT (1992) Inducible vectors for expression in mammalian cells. Curr Opin Biotechnol 3(5): 506-511.
40. Zhang N, Weber A et al (2003) An inducible nitric oxide synthase-luciferase reporter system for in vivo testing of anti-inflammatory compounds in transgenic mice. J Immunol 170(12): 6307-6319.
41. Zhou J, Suzuki T et al (2005) Interactions between prostaglandin E2, liver receptor homologue-1, and aromatase in breast cancer. Cancer Res 65(2): 657-663.